FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/12/098830 [Registered on: 10/12/2025] Trial Registered Prospectively
Last Modified On: 05/12/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   To compare Nidigdhikadi Yoga versus Shatyadi Churna in Bronchial Asthma 
Scientific Title of Study   Randomized Controlled Clinical Study to Evaluate the Efficacy of Nidigdhikadi Yoga and Shatyadi Churna in the Management of Tamaka Shwasa with Special Reference to Bronchial Asthma. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Randhir 
Designation  PG Scholar 
Affiliation  Institute For Ayurved Studies and Research Shri Krishna AYUSH University  
Address  Room no 56, Ground Floor, Institute for Ayurved Studies and Research Shri Krishna AYUSH University Umri Road, Sector 8 Kurukshetra 136118

Kurukshetra
HARYANA
136118
India 
Phone  7206212786  
Fax    
Email  randhirkataria666@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Neelam Kumari 
Designation  Chaiperson & HOD PG Department of Kayachikitsa 
Affiliation  Institute For Ayurved Studies and Research Shri Krishna AYUSH University  
Address  Room no 70, Ground Floor, Institute for Ayurved Studies and Research Shri Krishna AYUSH University Umri Road, Sector 8 Kurukshetra 136118

Kurukshetra
HARYANA
136118
India 
Phone  9671368058  
Fax    
Email  mehranilam@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Neelam Kumari 
Designation  Chaiperson & HOD PG Department of Kayachikitsa 
Affiliation  Institute For Ayurved Studies and Research Shri Krishna AYUSH University  
Address  Room no 70, Ground Floor, Institute for Ayurved Studies and Research Shri Krishna AYUSH University Umri Road, Sector 8 Kurukshetra 136118

Kurukshetra
HARYANA
136118
India 
Phone  9671368058  
Fax    
Email  mehranilam@gmail.com  
 
Source of Monetary or Material Support  
Institute for Ayurved Studies & Research Shri Krishna AYUSH University 
 
Primary Sponsor  
Name  Institute for Ayurved Studies & Research Shri Krishna AYUSH University 
Address  Sector 8 Umri Road Kurukshetra 136118 Haryana India 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Randhir  Institute For Ayurved Studies and Research   Room no 56, Ground Floor, Institute for Ayurved Studies and Research Shri Krishna AYUSH University Umri Road, Sector 8 Kurukshetra 136118
Kurukshetra
HARYANA 
7206212786

randhirkataria666@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Shri Krishna Ayush University  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:J454||Moderate persistent asthma. Ayurveda Condition: TAMAKASVASAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: NIDIGDHIKADI YOGA, Reference: Sushruta samhita Uttar Tantra 51/55, Route: Oral, Dosage Form: Churna/ Powder, Dose: 5(g), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 21 Days, anupAna/sahapAna: Yes(details: Honey), Additional Information: -
2Comparator ArmDrugClassical(1) Medicine Name: SHATYADI CHURNA, Reference: Charak Samhita Chikitsa Sthan 17/56-57, Route: Oral, Dosage Form: Churna/ Powder, Dose: 5(g), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 21 Days, anupAna/sahapAna: Yes(details: Honey), Additional Information: -
 
Inclusion Criteria  
Age From  30.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1. Patient willing for clinical trial and ready to give written Consent.
2. Patients between the age group of 30-60 years of either sex.
3. Patients fulfill the diagnostic criteria of Tamaka Shwasa (Bronchial Asthma).
4. Patients presented with cardinal features of Tamaka Shwasa as described in Ayurveda texts.
5. Newly Diagnosed and confirmed cases of Tamaka Shawasa (Bronchial Asthma) on the basis
of criteria given by NAEPP. 
 
ExclusionCriteria 
Details  1. Patient not willing to Clinical Trial
2. Patients not fulfilling the Inclusion Criteria
3. Patient having an Age below 30 and Above 60.
4. Patients having a medical history of CHF, CAD, Pulmonary hypertension, Diabetes Mellitus, Uncontrolled hypertension, CKD, and Autoimmune disorders.
5. During Pregnancy, Lactation period.
6. 7. Patients on Steroid therapy, Inhaler or any other medicines.
Patient Suffering from Secondary Respiratory Disease 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
1.Improvement in lung function: Measure changes in FEV1 (Forced Expiratory Volume in 1second),FVC,FVR or PEFR (Peak Expiratory Flow Rate).
2. Change in intensity and severity of Rhonchi and Wheeze.
3.Change in intensity and severity in the symptoms of Tamaka Shwasa. 
21 Days 
 
Secondary Outcome  
Outcome  TimePoints 
1. To assess the effect of the interventions on biochemical markers such as absolute eosinophil count and inflammatory indices(ESR and CRP).
2. Exacerbation frequency: Track changes in frequency of asthma exacerbations. 
21 Days 
 
Target Sample Size   Total Sample Size="66"
Sample Size from India="66" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   02/03/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

This randomized, open-label, parallel-group clinical trial will assess and compare the efficacy of two classical Ayurvedic formulations, Nidigdhikadi Yoga and Shatyadi Churna, in the management of Tamaka Shwasa (Bronchial Asthma). Sixty-six eligible participants will be randomly assigned into two groups. Group A will receive Nidigdhikadi Yoga 5 g twice daily before meals with honey, and Group B will receive Shatyadi Churna 5 g twice daily before meals with honey, for 21 days, followed by post-treatment follow-up until Day 42. Outcome evaluation will be performed using standardized subjective symptom scoring, spirometry parameters (FEV1, FVC, FEV1/FVC ratio, and PEFR), and inflammatory indices including absolute eosinophil count, ESR, and CRP. All participants will be advised appropriate pathya–apathya (dietary and lifestyle regimen) during the study. Institutional Ethics Committee (IEC) approval has been obtained and written informed consent will be taken prior to enrolment. The primary objective is to determine comparative improvement in asthma severity, respiratory function, and clinical response between the two interventions.

 
Close